Kcl + Glucose, Viaflo Baxter

Potassium chloride, the active ingredient in Kcl + Glucose, Viaflo Baxter, is an electrolyte solution presented as a sterile injectable solution for intravenous use. It is combined with glucose to address potassium depletion and provide rapid carbohydrate support in patients requiring parenteral therapy.

GNH USA supplies Kcl + Glucose, Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Kcl + Glucose is used intravenously to manage electrolyte and carbohydrate needs in several clinical situations. - Hypokalemia: restores serum potassium levels and prevents cardiac complications. - Hypoglycemia: supplies glucose for rapid correction of low blood sugar. - Peri‑operative care: maintains potassium balance and provides energy during surgery.

Intravenous administration of Kcl + Glucose may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema - Mild hyperglycemia - Transient nausea - Phlebitis

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia - Anaphylactic or severe allergic reaction - Acute hyperglycemia with osmotic diuresis - Renal impairment exacerbation

When using Kcl + Glucose, clinicians should observe several safety measures. - Serum potassium assessment: verify levels before and during infusion. - Blood glucose monitoring: check glucose concentrations regularly. - Renal function evaluation: adjust rate in patients with impaired clearance. - Avoid in hyperkalemia: do not administer if serum potassium is already elevated. - Caution in diabetic patients: monitor for hyperglycemic episodes. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kcl + Glucose can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - ACE inhibitors/ARBs: may cause hyperkalemia. - Potassium‑sparing diuretics: increase potassium levels. - Trimethoprim‑sulfamethoxazole: raise serum potassium.

Moderate Interactions (Monitor Closely): - Insulin: glucose may offset insulin’s hypoglycemic effect. - Beta‑blockers: can mask hypoglycemia signs. - Digoxin: potassium fluctuations affect toxicity.